Licorice-induced hypertension and common variants of genes regulating renal sodium reabsorption

Annals of Medicine

Volumn 42, Issue 6, 2010, Pages 465-474

  Miettinen, Helena E ^a   Piippo, Kirsi ^b   Hannila Handelberg, Tuula ^a   Paukku, Kirsi ^b   Hiltunen, Timo P ^a   Gautschi, Ivan ^c   Schild, Laurent ^c   Kontula, Kimmo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Research Program in Molecular Medicine   (Finland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

ENaC; Genetics; Hypertension; Licorice

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; ELECTROLYTE; EPITHELIAL SODIUM CHANNEL; POTASSIUM; RENIN;

11BETAHSD2 GENE; ADOLESCENT; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ALPHA ENAC GENE; ARTICLE; BETA ENAC GENE; DISEASE PREDISPOSITION; DNA DETERMINATION; ELECTROLYTE BLOOD LEVEL; FEMALE; FINLAND; GAMMA ENAC GENE; GENE; GENE FREQUENCY; GENE INSERTION; GENETIC SCREENING; GENETIC VARIABILITY; GLYCYRRHIZA; HETEROZYGOSITY; HUMAN; HYPERTENSION; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NUCLEOTIDE SEQUENCE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SCNN1A GENE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADOLESCENT; ADULT; ALDOSTERONE; EPITHELIAL SODIUM CHANNEL; FEMALE; GENETIC VARIATION; GLYCYRRHIZA; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; MINERALOCORTICOID EXCESS SYNDROME, APPARENT; MUTAGENESIS, INSERTIONAL; POTASSIUM; RENIN; SODIUM; YOUNG ADULT;

EID: 77955167526     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.499133     Document Type: Article

References (43)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556
2. Liddle GW, Bledsoe T, Coppage WSJ. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians. 1963;76: 199-213.
3. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S. Evidence for an unidentifi ed steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab. 1977;44:924-933
4. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab. 1979;49:757-764
5. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79:407-414
6. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shim-kets R, Lu Y, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11:76-82.
7. Baker EH, Dong YB, Sagnella GA, Rothwell M, Onipinla AK, Markandu ND, et al. Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet. 1998;351:1388-1392
8. Ambrosius WT, Bloem LJ, Zhou L, Rebhun JF, Snyder PM, Wagner MA, et al. Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension. 1999;34:631-637
9. Rayner BL, Owen EP, King JA, Soule SG, Vreede H, Opie LH, et al. A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens. 2003;21:921-926
10. Wong ZY, Stebbing M, Ellis JA, Lamantia A, Harrap SB. Genetic linkage of beta and gamma subunits of epithelial sodium channel to systolic blood pressure. Lancet. 1999;353:1222-1225
11. Hannila-Handelberg T, Kontula K, Tikkanen I, Tikkanen T, Fyhrquist F, Helin K, et al. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. BMC Med Genet. 2005;6:4.
12. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney iso-zyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet. 1995;10:394-399
13. van Uum SH, Hermus AR, Smits P, Thien T, Lenders JW. The role of 11 beta-hydroxysteroid dehydrogenase in the patho-genesis of hypertension. Cardiovasc Res. 1998;38:16-24.
14. Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, Krozowski ZS, et al. Examination of genotype and phe-notype relationships in 14 patients with apparent mineraloco-rticoid excess. J Clin Endocrinol Metab. 1998;83:2244-2254
15. White PC, Agarwal AK, Nunez BS, Giacchetti G, Mantero F, Stewart PM. Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase. Endocr Res. 2000;26:771-780
16. Watson B Jr, Bergman SM, Myracle A, Callen DF, Acton RT, Warnock DG. Genetic association of 11 beta-hydroxys-teroid dehydrogenase type 2 (HSD11B2) fl anking microsat-ellites with essential hypertension in blacks. Hypertension. 1996;28:478-482
17. Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ, et al. Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab. 1999;84:3745-3749
18. Agarwal AK, Giacchetti G, Lavery G, Nikkila H, Palermo M, Ricketts M, et al. CA-Repeat polymorphism in intron 1 of HSD11B2: effects on gene expression and salt sensitivity. Hypertension. 2000;36:187-194
19. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase defi ciency comes of age. Lancet. 1987;2:821-824
20. Whorwood CB, Sheppard MC, Stewart PM. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology. 1993;132:2287-2292
21. Tanahashi T, Mune T, Morita H, Tanahashi H, Isomura Y, Suwa T, et al. Glycyrrhizic acid suppresses type 2 11 beta-hydroxysteroid dehydrogenase expression in vivo. J Steroid Biochem Mol Biol. 2002;80:441-447
22. Epstein MT, Espiner EA, Donald RA, Hughes H. Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. BMJ. 1977;1:488-490
23. Forslund T, Fyhrquist F, Froseth B, Tikkanen I. Effects of licorice on plasma atrial natriuretic peptide in healthy volunteers. J Intern Med. 1989;225:95-99
24. Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension. 2001;38:1330-1336
25. Smolenicka Z, Bach E, Schaer A, Liechti-Gallati S, Frey BM, Frey FJ, et al. A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab. 1998;8383:1814-1817
26. Melander O, Orho M, Fagerudd J, Bengtsson K, Groop PH, Mattiasson I, et al. Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension. 1998;31:1118-1124
27. Persu A, Barbry P, Bassilana F, Houot AM, Mengual R, Lazdunski M, et al. Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension. Hypertension. 1998;32:129-137
28. Blomberg K, Hallikainen A. Suomessa kaupan olevien lakrit-sivalmisteiden glykyrritsiinipitoisuudet. Helsinki: Elintar-vikeviraston julkaisuja; 1993.
29. Conn J, Rovner JR, Cohen EL. Licorice-induced pseu-doaldosteronism. Hypertension, hypokalemia, aldoster-onopenia, and suppressed plasma renin activity. JAMA. 1968;205:80-84
30. Stormer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice\evaluation of health hazard. Food Chem Toxicol. 1993;31:303-312
31. Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hyper-tens. 2001;15:549-552
32. Sigurjonsdottir HA, Manhem K, Axelson M, Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hyper-tens. 2003;17:125-131
33. Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev. 2001;33:125-147
34. Iwai N, Baba S, Mannami T, Ogihara T, Ogata J. Association of a sodium channel alpha subunit promoter variant with blood pressure. J Am Soc Nephrol. 2002;13:80-85
35. Samaha FF, Rubenstein RC, Yan W, Ramkumar M, Levy DI, Ahn YJ, et al. Functional polymorphism in the carboxyl terminus of the alpha-subunit of the human epithelial sodium channel. J Biol Chem. 2004;279:23900-23907
36. Tong Q, Menon AG, Stockand JD. Functional polymorphisms in the alpha-subunit of the human epithelial Na+ channel increase activity. Am J Physiol Renal Physiol. 2006;290:F821-7.
37. Hiltunen TP, Hannila-Handelberg T, Petajaniemi N, Kan-tola I, Tikkanen I, Virtamo J, et al. Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit. J Hypertens. 2002;20:2383-2390
38. Shi H, Asher C, Yung Y, Kligman L, Reuveny E, Seger R, et al. Casein kinase 2 specifi cally binds to and phosphorylates the carboxy termini of ENaC subunits. Eur J Biochem. 2002;269:4551-4558
39. Shimkets RA, Lifton R, Canessa CM. In vivo phosphorylation of the epithelial sodium channel. Proc Natl Acad Sci USA. 1998;95:3301-3305
40. Findling JW, Raff H, Hansson JH, Lifton RP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab. 1997;82:1071-1074
41. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de La Sierra A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension. 2001;38:1204-1209
42. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592-599
43. Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, Haraguchi S, et al. Salt-sensitive hypertension in circadian clock-defi cient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med. 2010;16:67-75.